Wednesday, September 08, 2004
Westaim subsidiary Nucryst Pharmaceuticals reports positive drug trials
TORONTO (CP) - Nucryst Pharmaceuticals Corp., a subsidiary of Westaim Corp., said Tuesday initial reports suggest positive results from its drug used to treat a chronic inflammatory skin disease....More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment